Novel Bronchodilator Navafenterol in COPD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The European Respiratory Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The novel bronchodilator navafenterol: a phase 2a, multi-centre, randomised, double-blind, placebo-controlled crossover trial in COPD
Eur. Respir. J. 2021 Sep 09;[EPub Ahead of Print], D Singh, J Beier, C Astbury, MG Belvisi, CA Da Silva, A Jauhiainen, E Jimenez, A Lei, S Necander, JA Smith, UW Hamrén, W Xin, I PsallidasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.